Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
UBS
Fish and Richardson
AstraZeneca
Harvard Business School
Queensland Health
Healthtrust
QuintilesIMS

Generated: September 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075751

« Back to Dashboard

NDA 075751 describes DESONIDE, which is a drug marketed by G And W Labs Inc, Glenmark Pharms, Perrigo New York, Taro, Fougera Pharms, Taro Pharm, Teligent Pharma Inc, Glenmark Pharms Ltd, and Hi-tech Pharmacal, and is included in thirteen NDAs. It is available from ten suppliers. Additional details are available on the DESONIDE profile page.

The generic ingredient in DESONIDE is desonide. There are thirty drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the desonide profile page.
Summary for 075751
Tradename:DESONIDE
Applicant:Fougera Pharms
Ingredient:desonide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 075751
Medical Subject Heading (MeSH) Categories for 075751
Suppliers and Packaging for NDA: 075751
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESONIDE desonide OINTMENT;TOPICAL 075751 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0309 0168-0309-15 1 TUBE in 1 CARTON (0168-0309-15) > 15 g in 1 TUBE
DESONIDE desonide OINTMENT;TOPICAL 075751 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0309 0168-0309-60 1 TUBE in 1 CARTON (0168-0309-60) > 60 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.05%
Approval Date:Mar 12, 2001TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Fuji
McKinsey
Cantor Fitzgerald
Dow
Teva
Express Scripts
Fish and Richardson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.